Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03194620 · ClinicalTrials.gov registry record · NA
Absorption, Metabolism and Excretion of Dietary Polyphenolic Bioactives in Humans
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03194620 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 12 participants.
The verdict
NCT03194620, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The objectives of this study are to i) describe the absorption, distribution, metabolism and excretion (ADME) and pharmacokinetic parameters of selected dietary (poly)phenols in humans; and ii) to compare the ADME and pharmacokinetic parameters of selected dietary (poly)phenols in humans.
Interventions
- OTHER Thearubigins
- OTHER Theaflavins
- OTHER Procyanidin Dimer B2 (DB2)
- OTHER (-)-Epigallocatechin-3-O-gallate (EGCG)
- OTHER (-)-Epicatechin-3-O-gallate (ECG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-01-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03194620
The ClinicalTrials.gov registry entry for NCT03194620 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Thearubigins is the first listed.
NCT03194620 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03194620 about?
NCT03194620 is a clinical study titled "Absorption, Metabolism and Excretion of Dietary Polyphenolic Bioactives in Humans". The objectives of this study are to i) describe the absorption, distribution, metabolism and excretion (ADME) and pharmacokinetic parameters of selected dietary (poly)phenols in humans; and ii) to compare the ADME and pharmacokinetic parameters of selected dietary (poly)phenols in humans.
What is the current status of trial NCT03194620?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2016-08. Estimated completion is 2017-01-12.
What interventions are being tested in trial NCT03194620?
The interventions under investigation include: Thearubigins (OTHER), Theaflavins (OTHER), Procyanidin Dimer B2 (DB2) (OTHER), (-)-Epigallocatechin-3-O-gallate (EGCG) (OTHER), (-)-Epicatechin-3-O-gallate (ECG) (OTHER).
Who is sponsoring clinical trial NCT03194620?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.